Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

LEVOleucovorin

LEVOleucovorin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Khapzory INJECTION, INTRAVENOUS 175 mg, 300 mg    
Fusilev POWDER FOR INJECTION, INTRAVENOUS 50 mg    
VIEW MORE Antidotes
CLASS
921200
Comments:

LEVOleucovorin calcium (Fusilev) and LEVOleucovorin sodium (Khapzory) is to be interchanged to leucovorin. LEVOleucovorin is dosed at 1/2 the prescribded leucovorin dose.

Khapzory (LEVOleucovorin sodium) is formulary restricted for use when leucovorin injection is unavailable or patient is utilizing Khapzory patient assistance program.

Fusilev (LEVOleucovorin calcium) has been discontinuted by the manufacturer. Khapzory (LEVOleucovorin sodium) is therapeutically interchangeable with Fusilev (1:1 conversion).

Reviewed: October 28, 2008, and November 16, 2010, and 26 Feb 2019 (Khapzory)

 
Last updated: Mar. 6, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved